Control joins Axway's Global Track & Trace Initiative
Control, a Domino Group company based in the US, has joined Axway's in conjunction to Global Track & Trace Alliance, which was created to provide a complete solution for global serialisation and track and trace efforts.
Control, a Domino Group company based in the US, has joined Axway's in conjunction to Global Track & Trace Alliance, which was created to provide a complete solution for global serialisation and track and trace efforts.
The move means Control will offer a wide range of solutions, including validated mass serialisation and aggregation software in exchange for access to Axway's expertise in ePedigree and track and trace.
The alliance comprises various organisations that contribute their respective expertise in securing the pharmaceutical supply chain. Axway established the Global Track & Trace Alliance in April 2008.
Axway is the leading global provider of collaborative business solutions. Axway establishes the dynamic connections within and among enterprises that make companies easier to do business with.
The global pharmaceutical industry is continually in search of new approaches and technologies to improve efficiencies in their production lines, while ensuring the safety and security of the prescription drugs that travel through several layers of manufacturers, wholesalers and distributors before reaching patients. With the escalating threat of counterfeit drugs, the US Food and Drug Administration, many states in the US, and several European countries have enacted or proposed regulations that will require serialisation of products to enable prescription drugs to be tracked through the entire healthcare supply chain. As a result, all organisations involved require solutions to improve production efficiencies and provide visibility into the supply chain to safeguard against counterfeiting and diversion. The principal goal of Axway's Global Track & Trace Initiative is to offer a solution that achieves these objectives.
Control will offer a range of solutions, including ink jet, high resolution laser printing, data matrix coding and RFID technologies for automating and optimising pharmaceutical manufacturing production lines and data tracking.
"Pharmaceutical companies, contract manufacturers, and contract packagers are increasingly interested in deploying solutions that meet their business objectives as the healthcare industry unites against counterfeiting and diversion," said Sia Zadeh, director, business development, Axway. "Axway will continue to bring additional partners into the alliance to help formulate the strongest offering for the life sciences industry. We believe assembling a best-of-breed solution that leverages the expertise of numerous organisations will ultimately be the most complete solution to safeguard the pharmaceutical supply chain and consumers from counterfeiting and diversion."
"Today's pharmaceutical companies need to improve manufacturing production line efficiencies to meet the global demand for prescription drugs,. said John Pitts, sales and marketing director, Control. "This alliance marks an important step forward for the pharmaceutical companies, contract manufacturers and contract packagers. It brings together organisations with the right expertise to provide the best solution for key business requirements and regulatory compliance."
Axway's contribution will consist of its Synchrony Supply Chain Integrity Suite, which improves operational efficiency through supply chain visibility, assures data integrity in supply chain transactions, enables product authentication, streamlines reverse logistics processes and can be integrated with existing enterprise resource planning (ERP) systems.
